The 91探花has entered into a five-year agreement with Singapore鈥檚 Nanyang Technological University to collaborate in bioengineering research, an arrangement that officials on both sides anticipate will foster important advances in one of the world鈥檚 hottest scientific arenas.
The Singapore-91探花 Alliance, officially created last week when 91探花President Richard L. McCormick signed a collaboration agreement with officials in Singapore, will initially focus its efforts in two areas: tissue engineering and distributed diagnosis and home healthcare (D2H2). Under the tissue engineering initiative, scientists will explore methods to 鈥済row鈥� a pharynx and esophagus in the laboratory.
The D2H2 emphasis involves using technology and tele-medicine to bring medical care to people and areas that might otherwise miss out. Projects include the development of a home ultrasound system and technology and techniques to monitor patients via the Internet and point-of-care diagnostic tools that can be used at home.
Yongmin Kim, chair of the 91探花Department of Bioengineering, said the alliance will help build stronger international connections for the 91探花while harnessing the strengths of both institutions to advance research with potential applications both in the U.S. and overseas.
鈥淭ogether we can generate new technology, new medical devices, to not only improve healthcare in advanced countries, but also in third-world countries,鈥� he said.
Louis Lim, executive director of the Biomedical Research Council of Singapore鈥檚 Agency for Science, Technology and Research, said the alliance represents a beginning for Singapore.
鈥淭his promising partnership will only be the tip of the iceberg as we develop Singapore as a world-class center for bioengineering research,鈥� he said.